Zion Laboratory Services, INC.

Zion Laboratory Services, INC. was paid $100K by Medicaid between Jan 2018 and Dec 2018, across 8 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 84% of everything it billed.

33Billing provider infoZION LABORATORY SERVICES, INC.
PHARR, TX 78577

33aNPI1366728545assigned 11/01/2011

33bProvider typeClinical Medical Laboratory

28Total paid$100K

24GClaims1,101

24DCodes billed8

24AFirst – last monthJan 2018 – Dec 2018

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#150 of 436

Median peer was paid$17K

This provider vs. median5.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,101	$100K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	84%	243	233	$84K
87486		7.1%	243	233	$7K
87581		7.1%	243	233	$7K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	1.1%	32	31	$1K
87507		<1%	14	14	$480.24
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	170	167	$51.26
85025	Blood count; complete (CBC), automated, and automated differential WBC count	0%	13	13	$0.00
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	0%	143	142	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCONDE, DULCE (EXECUTIVE DIRECTOR)